We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Motif Bio Plc | LSE:MTFB | London | Ordinary Share | GB00BVVT4H71 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.50 | 0.40 | 0.55 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
14/2/2019 11:58 | Mausaeus @Mausaeus 3h3 hours ago More Been on to #MTFB. TBF they're flabbergasted they didn't get it. They said they'd given a complete response to the FDA to address their concerns following consultations with 3 of the top liver experts in the US. They reckon they'll meet the FDA with the next two weeks. | timw3 | |
14/2/2019 11:57 | mid is 666 lol. | babbler | |
14/2/2019 11:55 | Bought a few for a geg | volsung | |
14/2/2019 11:54 | Supposedly a labelling error , which is incredibly naive and shoddy from co if true. Though if true it’s now stupidly cheap | timw3 | |
14/2/2019 11:51 | 10p is still 75% down on the day. | sunnybeachboy | |
14/2/2019 11:50 | me too. This is going over 10p today imo | babbler | |
14/2/2019 11:45 | Yes I rt'd it Glen@cele7tial tweet | alexios1201 | |
14/2/2019 11:45 | MOTIF is very different to IMM. The FDA said IMM Lupus didn't work, different here, the FDA said they need more information Clearly it works as it passed staged 3, clearly this will be approved, once MOTIF submit further information Its a no brainer at this level, even if they have to raise more money to get there | timw3 | |
14/2/2019 11:43 | Bid 6 26Ask 6.5Moving on up.... | sunnybeachboy | |
14/2/2019 11:40 | FDA does not yet agree not outright rejection - Have a minimum of a month for hearing - | tomboyb | |
14/2/2019 11:39 | Can you post that if you are on twitter? | glenbo1 | |
14/2/2019 11:38 | This looks fantastic now | kirk 6 | |
14/2/2019 11:38 | Obviously the FDA doesn't agree yet. It's up to the company to supply more info to support the application. | gisjob2 | |
14/2/2019 11:36 | What a farce. should go back up to 10+ quick Liver safe in REVIVE 1&2 #MTFB See their presentation at ESCMID 2018. … | timw3 | |
14/2/2019 11:33 | Stopped trading these months ago but they've hung around on my watchlist. Now dropped from that, day trader territory only unless you're confident about a fund raise or two over the next couple of years of additional phase 3 trials to get the liver data?Good luck to lth but perhaps accept the loss and move on? I did with IMM and more than made up since, all imo dyor ofc. | rathean | |
14/2/2019 11:33 | because they may issue more shares? | stansmith3 | |
14/2/2019 11:32 | What price for the raise ? | gisjob2 | |
14/2/2019 11:27 | Time will prove one of us right. | regandharry5 | |
14/2/2019 11:27 | I reckon we could see 8p by end of day - But we'll see - | tomboyb | |
14/2/2019 11:26 | This is going to explode | kirk 6 | |
14/2/2019 11:26 | Level 2 anyone?? | herb clark | |
14/2/2019 11:24 | Bid 6.1Ask 6.3 | sunnybeachboy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions